| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919212 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
p16INK4A is strongly associated with relapse in SCC of the anus and identifies patients with very poor rates of relapse-free and overall survival. Primary and recurrent anal cancer expresses wild type KRAS, unaffected by treatment, supporting trials targeting EGFR in poor risk/recurrent anal cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Duncan C Gilbert, Anthony Williams, Kimberley Allan, Joanna Stokoe, Tim Jackson, Suzanne Linsdall, Charles MH Bailey, Jeff Summers,